hero image
Dr. Graham  Roche-Nagle - University Health Network. Toronto, ON, CANADA

Dr. Graham Roche-Nagle

Vascular Surgeon | University Health Network

Toronto, ON, CANADA

Dr. Graham Roche-Nagle specialty interests include open/endovascular abdominal and thoracic aortic aneurysm repair.

Media

Publications:

Documents:

Photos:

Dr. Graham  Roche-Nagle Photo

Videos:

Audio/Podcasts:

Social

Biography

Dr Graham Roche-Nagle is a native of Waterford, Ireland. He received his medical degree from the Royal College of Surgeons in Ireland in1998 and finished his clinical training on the Irish Senior Registrar Training Program. He then completed a 2 year fellowship in vascular surgery at Toronto General Hospital and St Michaels Hospital Toronto. He is certified in general vascular surgery from the Royal College of Surgeons in Ireland and also holds certification from the European Board for Vascular Surgery. Dr Roche-Nagle in addition has been awarded a MBA in Healthcare Management (University College Dublin) and a Masters in Medical Education (Queens University, Belfast).
He was appointed as an Assistant Professor in the Department of Vascular Surgery UHN in July 2009.

Industry Expertise (1)

Research

Areas of Expertise (8)

Surgery

Vascular Surgery

Aortic Aneurysm Repair

Peripheral Artery Bypass/Intervention

Carotid Artery Surgery

Arterio-Venous Fistula Construction

Venous Disease

Thoracic Outlet Syndrome

Education (6)

Queens University Belfast: Masters, Medical Education 2011

University of Toronto: Fellowship, Vascular Surgery 2009

European Board of Surgery: European Board of Surgery, Qualifications in Vascular Surgery 2008

Royal College of Surgeons: Intercollegiate Specialty Examination (FRCSI), Surgery 2008

University College Dublin: M.B.A., Health Services Management 2004

Royal College of Surgeons in Ireland: M.D., Medicine 2002

Media Appearances (1)

The Cautionary Tale Relating to Stamkos' Injury

Sports Net  

2016-04-03

Dr. Graham Roche-Nagle, a vascular surgeon at the Peter Munk Cardiac Centre in Toronto shares the risks and concerns surrounding Steven Stamkosā€™ injury...

view more

Articles (5)

PC078. Vascular Complications and Procedures Following Trans Catheter Aortic Valve Implantation (TAVI)


Journal of Vascular Surgery

2016 Transcatheter aortic valve implantation (TAVI) is an established treatment option for patients with aortic valve stenosis and high surgical risk. Different access routes have been used for TAVI, with percutaneous transfemoral being the preferred approach ...

view more


Thoracic aortic endografting facilitates the resection of tumors infiltrating the aorta


The Journal of Thoracic and Cardiovascular Surgery

2014 We and others have reported the early experience with off-label use of thoracic aortic endografts to facilitate the resection of tumors infiltrating the aorta. We describe our extended experience and long-term outcome using this innovative approach ...

view more


Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft M D Wheatcroft


Vascular

2011 The use of prosthetic grafts in below-knee bypasses may be necessary in patients with no available autologous vein and critical limb ischemia not amenable to angioplasty. Such conduits, however, have generally yielded disappointing results...

view more


Antimetastatic activity of a cyclooxygenase-2 inhibitor


British Journal of Cancer

2004 Cyclooxygenase-2 (COX-2) expression is increased in breast cancer and surgery has been shown to increase the growth of metastatic tumours. We investigated the effect of selective COX-2 inhibition on the growth of metastases in either an experimental metastasis model or following excision of a murine primary breast tumour...

view more


Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer


British Journal of Cancer

2002 The effect of selective and non-selective cyclo-oxygenase inhibition on tumour growth and metastasis in an orthotopic model of breast cancer was investigated. 4T1 mammary adenocarcinoma cells were injected into the mammary fat pad of female BALB/c mice...

view more


 Your profile is not published.

Contact